Epstein David R — SEC insider filings

SEC reporting owner CIK 1445826. 69 insider filings on record with FilingPulse; latest filed 2026-11-19.

Transaction summary — filings shown

Covers the 50 most recent of 69 filings on record, filed 2021-11-22 to 2026-11-19. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Seagen Inc. (SGEN)CEO, Director4—1 leg · 10,620 sh · $2,262,16617
AgomAb Therapeutics NV (AGMB)Director613 legs · 59,980 sh · $439,679——
Tempus AI, Inc. (TEM)Director19—16 legs · 5,950 sh · $337,9273
Axcella Health Inc. (AXLA)Director71 leg · 26,178 sh · $50,000—12
Rubius Therapeutics, Inc. (RUBY)Director21 leg · 30,000 sh · $43,329—1
Evelo Biosciences, Inc. (EVLO)Director101 leg · 17,123 sh · $25,000—33
Senti Biosciences, Inc. (SNTI)Director2——3

Insider filings — Epstein David R

FiledFormIssuerReported transactionsSource
2026-11-194AgomAb Therapeutics NV (AGMB)Purchase (P): 5,000 @ $5.57EDGAR
2026-11-164AgomAb Therapeutics NV (AGMB)Purchase (P): 5,000 @ $5.99 · Purchase (P): 20 @ $6 · Purchase (P): 5,000 @ $5.75 · Purchase (P): 4,960 @ $6.02EDGAR
2026-11-064AgomAb Therapeutics NV (AGMB)Purchase (P): 5,000 @ $6.81 · Purchase (P): 5,000 @ $6.91 · Purchase (P): 5,000 @ $6.98EDGAR
2026-11-044Tempus AI, Inc. (TEM)Sale (S): 370 @ $74.29EDGAR
2026-10-224AgomAb Therapeutics NV (AGMB)Purchase (P): 5,000 @ $8.86 · Purchase (P): 5,000 @ $8.90EDGAR
2026-10-094AgomAb Therapeutics NV (AGMB)Purchase (P): 5,000 @ $8.90EDGAR
2026-10-074AgomAb Therapeutics NV (AGMB)Purchase (P): 5,000 @ $8.57 · Purchase (P): 5,000 @ $8.70EDGAR
2026-09-034Tempus AI, Inc. (TEM)Sale (S): 250 @ $65.55EDGAR
2026-08-054Tempus AI, Inc. (TEM)Sale (S): 370 @ $43.40EDGAR
2026-06-034Tempus AI, Inc. (TEM)Sale (S): 250 @ $49.40EDGAR
2026-05-264Tempus AI, Inc. (TEM)Grant/award (A): 5,913 @ $0EDGAR
2026-03-044Tempus AI, Inc. (TEM)Sale (S): 250 @ $50.69EDGAR
2026-02-044Tempus AI, Inc. (TEM)Sale (S): 370 @ $59.41EDGAR
2025-12-034Tempus AI, Inc. (TEM)Sale (S): 250 @ $75.55EDGAR
2025-11-054Tempus AI, Inc. (TEM)Sale (S): 370 @ $90EDGAR
2025-09-044Tempus AI, Inc. (TEM)Sale (S): 250 @ $73.64EDGAR
2025-08-054Tempus AI, Inc. (TEM)Sale (S): 370 @ $55.16EDGAR
2025-06-044Tempus AI, Inc. (TEM)Sale (S): 250 @ $55.20EDGAR
2025-05-224Tempus AI, Inc. (TEM)Grant/award (A): 1,997 @ $0EDGAR
2025-05-054Tempus AI, Inc. (TEM)Sale (S): 370 @ $53.50EDGAR
2025-03-194Tempus AI, Inc. (TEM)Sale (S): 990 @ $46.83EDGAR
2025-03-054Tempus AI, Inc. (TEM)Sale (S): 250 @ $57.52EDGAR
2025-02-054Tempus AI, Inc. (TEM)Sale (S): 370 @ $53.31EDGAR
2024-12-134Tempus AI, Inc. (TEM)Sale (S): 620 @ $41.81EDGAR
2024-06-174Tempus AI, Inc. (TEM)Grant/award (A): 28,514 @ $0EDGAR
2023-12-154Seagen Inc. (SGEN)Disposition to issuer (D): 16,407 @ $229 · Disposition to issuer (D): 2,896 (derivative) · Disposition to issuer (D): 240,451 (derivative) · Disposition to issuer (D): 224,000 (derivative) · Disposition to issuer (D): 80,541 (derivative) · Disposition to issuer (D): 39,650 (derivative) · +6 moreEDGAR
2023-11-134Seagen Inc. (SGEN)Sale (S): 10,620 @ $213.01EDGAR
2023-08-174Seagen Inc. (SGEN)Grant/award (A): 39,650 @ $0EDGAR
2022-11-144Seagen Inc. (SGEN)Grant/award (A): 107,389 @ $0 · Grant/award (A): 2,896 (derivative) @ $0 · Grant/award (A): 240,451 (derivative) @ $0 · Grant/award (A): 400,000 (derivative) @ $0EDGAR
2022-07-154Senti Biosciences, Inc. (SNTI)Grant/award (A): 125,000 (derivative) @ $0EDGAR
2022-06-304Evelo Biosciences, Inc. (EVLO)Option exercise (M): 2,053 @ $0 · Option exercise (M): 2,874 @ $0 · Option exercise (M): 2,053 (derivative) @ $0 · Option exercise (M): 2,874 (derivative) @ $0EDGAR
2022-06-134Evelo Biosciences, Inc. (EVLO)Grant/award (A): 20,000 (derivative) @ $0EDGAR
2022-06-104Dynamics Special Purpose Corp. (SNTI)Grant/award (A): 112,519 @ $0 · Option exercise (M): 112,519 (derivative)EDGAR
2022-06-034Axcella Health Inc. (AXLA)Grant/award (A): 47,059 @ $0EDGAR
2022-06-014Evelo Biosciences, Inc. (EVLO)Option exercise (M): 2,052 @ $0 · Option exercise (M): 2,873 @ $0 · Option exercise (M): 2,052 (derivative) @ $0 · Option exercise (M): 2,873 (derivative) @ $0EDGAR
2022-05-314Evelo Biosciences, Inc. (EVLO)Purchase (P): 17,123 @ $1.46EDGAR
2022-05-134Rubius Therapeutics, Inc. (RUBY)Grant/award (A): 499,762 (derivative) @ $0EDGAR
2022-05-024Evelo Biosciences, Inc. (EVLO)Option exercise (M): 2,053 @ $0 · Option exercise (M): 2,873 @ $0 · Option exercise (M): 2,053 (derivative) @ $0 · Option exercise (M): 2,873 (derivative) @ $0EDGAR
2022-04-224Rubius Therapeutics, Inc. (RUBY)Purchase (P): 30,000 @ $1.44EDGAR
2022-04-014Evelo Biosciences, Inc. (EVLO)Option exercise (M): 2,052 @ $0 · Option exercise (M): 2,874 @ $0 · Option exercise (M): 2,052 (derivative) @ $0 · Option exercise (M): 2,874 (derivative) @ $0EDGAR
2022-03-214Axcella Health Inc. (AXLA)Option exercise (M): 1,535 · Grant/award (A): 50,000 (derivative) @ $0 · Option exercise (M): 1,535 (derivative) @ $0EDGAR
2022-03-184Axcella Health Inc. (AXLA)Purchase (P): 26,178 @ $1.91EDGAR
2022-03-014Evelo Biosciences, Inc. (EVLO)Option exercise (M): 2,053 @ $0 · Option exercise (M): 2,873 @ $0 · Option exercise (M): 2,053 (derivative) @ $0 · Option exercise (M): 2,873 (derivative) @ $0EDGAR
2022-02-234Axcella Health Inc. (AXLA)Option exercise (M): 1,534 · Option exercise (M): 1,534 (derivative) @ $0EDGAR
2022-01-314Evelo Biosciences, Inc. (EVLO)Option exercise (M): 2,052 @ $0 · Option exercise (M): 2,873 @ $0 · Option exercise (M): 2,052 (derivative) @ $0 · Option exercise (M): 2,873 (derivative) @ $0EDGAR
2022-01-204Axcella Health Inc. (AXLA)Option exercise (M): 1,535 · Option exercise (M): 1,535 (derivative) @ $0EDGAR
2022-01-034Evelo Biosciences, Inc. (EVLO)Option exercise (M): 2,052 @ $0 · Option exercise (M): 2,874 @ $0 · Option exercise (M): 2,052 (derivative) @ $0 · Option exercise (M): 2,874 (derivative) @ $0EDGAR
2021-12-204Axcella Health Inc. (AXLA)Option exercise (M): 1,535 · Option exercise (M): 1,535 (derivative) @ $0EDGAR
2021-12-014Evelo Biosciences, Inc. (EVLO)Option exercise (M): 2,053 @ $0 · Option exercise (M): 2,873 @ $0 · Option exercise (M): 2,053 (derivative) @ $0 · Option exercise (M): 2,873 (derivative) @ $0EDGAR
2021-11-224Axcella Health Inc. (AXLA)Option exercise (M): 1,534 · Option exercise (M): 1,534 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-26 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1445826 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs